JEREMY KAUP: Open Payments
NPI 1649970773 · STURTEVANT, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 4 payments from 4 companies in 2025. Trend: 2023 $152 · 2024 $350 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $109 |
| Teva Pharmaceuticals USA, Inc. | 1 | $97 |
| Otsuka America Pharmaceutical, Inc. | 1 | $96 |
| Neurocrine BioSciences, Inc. | 1 | $89 |
Products named: CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA, INGREZZA.
Industry payments across WI — which companies pay providers there.
